Sectoral Asset Management
Latest statistics and disclosures from Sectoral Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are UNH, HQY, NARI, ATRC, SYNH, and represent 13.50% of Sectoral Asset Management's stock portfolio.
- Added to shares of these 10 stocks: HQY (+$16M), BHVN (+$13M), TNDM (+$7.4M), BMRN (+$7.3M), OM (+$5.1M), HALO (+$5.0M), ITOS, IRTC, IMGN, IOVA.
- Started 15 new stock positions in BMY, JSPR, HALO, CNC, BHVN, IOVA, MOH, IRTC, APLS, CI. AXNX, OM, HQY, IMGN, CYTK.
- Reduced shares in these 10 stocks: Arena Pharmaceuticals (-$21M), ALHC (-$10M), DH (-$7.8M), TGTX (-$7.6M), NVTA (-$6.3M), FOLD (-$5.9M), BLI (-$5.3M), EVH (-$5.2M), NEO (-$5.0M), BBIO.
- Sold out of its positions in ALHC, ALGS, ALVR, Arena Pharmaceuticals, BLI, BBIO, DH, DOCS, NVTA, MEIP. NTRA, NEO, OLK, TDOC, TGTX, VIR, BBLN.
- Sectoral Asset Management was a net seller of stock by $-25M.
- Sectoral Asset Management has $563M in assets under management (AUM), dropping by -15.22%.
- Central Index Key (CIK): 0001274413
Tip: Access up to 7 years of quarterly data
Positions held by Sectoral Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sectoral Asset Management
Companies in the Sectoral Asset Management portfolio as of the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| UnitedHealth (UNH) | 3.0 | $17M | +7% | 33k | 509.97 | |
| Healthequity (HQY) | 2.9 | $16M | NEW | 240k | 67.44 | |
| Inari Medical Ord (NARI) | 2.6 | $15M | 161k | 90.64 | ||
| AtriCure (ATRC) | 2.5 | $14M | -5% | 218k | 65.67 | |
| Syneos Health Cl A (SYNH) | 2.5 | $14M | +7% | 176k | 80.95 | |
| R1 Rcm (RCM) | 2.5 | $14M | -13% | 529k | 26.76 | |
| Inspire Med Sys (INSP) | 2.4 | $13M | 52k | 256.69 | ||
| Johnson & Johnson (JNJ) | 2.3 | $13M | -2% | 73k | 177.22 | |
| Evolent Health Cl A (EVH) | 2.2 | $13M | -28% | 392k | 32.30 | |
| Biohaven Pharmaceutical Holding (BHVN) | 2.2 | $13M | NEW | 106k | 118.57 | |
| Insmed (INSM) | 2.2 | $12M | 528k | 23.50 | ||
| Ortho Clinical Diagnostics H Ord Shs (OCDX) | 2.2 | $12M | -23% | 665k | 18.66 | |
| Tenet Healthcare Corporation (THC) | 2.2 | $12M | 143k | 85.96 | ||
| Arvinas Ord (ARVN) | 2.0 | $11M | -6% | 166k | 67.30 | |
Setup an alertSectoral Asset Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Arcus Biosciences Incorporated (RCUS) | 1.9 | $11M | +19% | 339k | 31.56 | |
| Agiliti (AGTI) | 1.8 | $10M | +6% | 480k | 21.10 | |
| Thermo Fisher Scientific (TMO) | 1.8 | $9.9M | -2% | 17k | 590.67 | |
| Ptc Therapeutics I (PTCT) | 1.8 | $9.9M | 264k | 37.31 | ||
| Abbvie (ABBV) | 1.7 | $9.8M | -12% | 60k | 162.11 | |
| Privia Health Group (PRVA) | 1.7 | $9.7M | -9% | 362k | 26.73 | |
| Pfizer (PFE) | 1.7 | $9.6M | -11% | 185k | 51.77 | |
| Effector Therapeutics (EFTR) | 1.7 | $9.6M | 2.4M | 4.01 | ||
| Tandem Diabetes Care (TNDM) | 1.6 | $9.3M | +404% | 80k | 116.29 | |
| Silk Road Medical Inc Common (SILK) | 1.5 | $8.6M | 209k | 41.29 | ||
| Exelixis (EXEL) | 1.5 | $8.2M | -11% | 364k | 22.67 | |
| Eli Lilly & Co. (LLY) | 1.4 | $8.2M | -3% | 29k | 286.39 | |
| BioMarin Pharmaceutical (BMRN) | 1.4 | $8.1M | +937% | 105k | 77.10 | |
| Turning Point Therapeutics I (TPTX) | 1.3 | $7.5M | +27% | 281k | 26.85 | |
| Iteos Therapeutics (ITOS) | 1.3 | $7.5M | +192% | 234k | 32.18 | |
| Fate Therapeutics (FATE) | 1.3 | $7.5M | 193k | 38.77 | ||
| Shockwave Med (SWAV) | 1.3 | $7.3M | 35k | 207.37 | ||
| Abbott Laboratories (ABT) | 1.3 | $7.0M | -13% | 60k | 118.36 | |
| Denali Therapeutics (DNLI) | 1.2 | $6.7M | +9% | 207k | 32.17 | |
| Health Catalyst (HCAT) | 1.2 | $6.6M | +4% | 252k | 26.13 | |
| Seagen (SGEN) | 1.1 | $5.9M | +11% | 41k | 144.06 | |
| Amicus Therapeutics (FOLD) | 1.0 | $5.9M | -49% | 624k | 9.47 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.0 | $5.5M | +14% | 120k | 45.99 | |
| Certara Ord (CERT) | 1.0 | $5.5M | -27% | 256k | 21.48 | |
| Bellus Health Com New (BLU) | 1.0 | $5.4M | +9% | 791k | 6.88 | |
| Intellia Therapeutics (NTLA) | 0.9 | $5.2M | 72k | 72.67 | ||
| Blueprint Medicines (BPMC) | 0.9 | $5.2M | +24% | 82k | 63.88 | |
| Horizon Therapeutics Pub L SHS (HZNP) | 0.9 | $5.2M | 50k | 105.20 | ||
| Outset Med (OM) | 0.9 | $5.1M | NEW | 111k | 45.40 | |
| Halozyme Therapeutics (HALO) | 0.9 | $5.0M | NEW | 126k | 39.88 | |
| Humana (HUM) | 0.9 | $5.0M | +135% | 12k | 435.14 | |
| STAAR Surgical Company (STAA) | 0.9 | $5.0M | 63k | 79.90 | ||
| Mirati Therapeutics (MRTX) | 0.9 | $4.9M | -21% | 60k | 82.22 | |
| Rocket Pharmaceuticals (RCKT) | 0.9 | $4.8M | -20% | 304k | 15.86 | |
| Merck & Co (MRK) | 0.8 | $4.7M | +14% | 58k | 82.04 | |
| Boston Scientific Corporation (BSX) | 0.8 | $4.6M | -21% | 103k | 44.29 | |
| Irhythm Technologies (IRTC) | 0.8 | $4.5M | NEW | 29k | 157.47 | |
| Danaher Corporation (DHR) | 0.8 | $4.4M | -10% | 15k | 293.33 | |
| Arcutis Biotherapeutics (ARQT) | 0.7 | $4.2M | -10% | 219k | 19.26 | |
| ImmunoGen (IMGN) | 0.7 | $4.2M | NEW | 879k | 4.76 | |
| Aerovate Therapeutics (AVTE) | 0.7 | $4.0M | -22% | 219k | 18.33 | |
| Treace Med Concepts (TMCI) | 0.7 | $4.0M | -8% | 211k | 18.91 | |
| Novavax (NVAX) | 0.7 | $3.7M | +13% | 51k | 73.64 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $3.7M | NEW | 222k | 16.65 | |
| Biogen Idec (BIIB) | 0.6 | $3.6M | 17k | 210.62 | ||
| Dex (DXCM) | 0.6 | $3.6M | +37% | 7.0k | 511.57 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $3.5M | NEW | 70k | 50.81 | |
| Exscientia Ads (EXAI) | 0.6 | $3.4M | -21% | 236k | 14.40 | |
| Anthem (ANTM) | 0.6 | $3.4M | +22% | 6.9k | 491.16 | |
| Repare Therapeutics Ord (RPTX) | 0.6 | $3.4M | +14% | 238k | 14.24 | |
| Centene Corporation (CNC) | 0.6 | $3.3M | NEW | 39k | 84.18 | |
| Axonics Modulation Technolog (AXNX) | 0.6 | $3.1M | NEW | 50k | 62.61 | |
| Convey Hldg Parent (CNVY) | 0.5 | $3.1M | -10% | 468k | 6.54 | |
| Maravai Lifesciences Holdings (MRVI) | 0.5 | $3.0M | -22% | 85k | 35.27 | |
| Moderna (MRNA) | 0.5 | $3.0M | -4% | 17k | 172.28 | |
| Molina Healthcare (MOH) | 0.5 | $2.7M | NEW | 8.2k | 333.62 | |
| Amgen (AMGN) | 0.5 | $2.7M | -6% | 11k | 241.79 | |
| Rallybio Corp (RLYB) | 0.5 | $2.7M | +27% | 385k | 6.98 | |
| Cytokinetics (CYTK) | 0.5 | $2.6M | NEW | 70k | 36.81 | |
| 908 Devices (MASS) | 0.5 | $2.6M | 135k | 19.01 | ||
| Cigna Corp (CI) | 0.5 | $2.6M | NEW | 11k | 239.62 | |
| Medtronic SHS (MDT) | 0.4 | $2.5M | -51% | 23k | 110.95 | |
| Jasper Therapeutics (JSPR) | 0.4 | $2.4M | NEW | 675k | 3.55 | |
| Talaris Therapeutics (TALS) | 0.4 | $2.3M | -12% | 229k | 9.84 | |
| Regeneron Pharmaceuticals (REGN) | 0.4 | $2.1M | -10% | 3.0k | 698.36 | |
| Bristol Myers Squibb (BMY) | 0.4 | $2.0M | NEW | 28k | 73.04 | |
| Sight Sciences (SGHT) | 0.3 | $2.0M | 170k | 11.56 | ||
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.3 | $1.9M | -6% | 7.3k | 260.95 | |
| Edwards Lifesciences (EW) | 0.3 | $1.9M | +44% | 16k | 117.73 | |
| Stryker Corporation (SYK) | 0.3 | $1.9M | -19% | 7.0k | 267.34 | |
| Better Therapeutics Common Stock (BTTX) | 0.3 | $1.7M | -9% | 879k | 1.98 | |
| Checkmate Pharmaceuticals In (CMPI) | 0.3 | $1.7M | 542k | 3.19 | ||
| Gilead Sciences (GILD) | 0.3 | $1.5M | +9% | 25k | 59.44 | |
| Align Technology (ALGN) | 0.2 | $1.1M | -70% | 2.4k | 436.02 | |
| Procaps Group Sa SHS (PROC) | 0.2 | $929k | -50% | 109k | 8.50 | |
| Beigene Sponsored Adr (BGNE) | 0.2 | $864k | -4% | 4.6k | 188.65 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.1 | $719k | 6.1k | 117.31 | ||
| Illumina (ILMN) | 0.1 | $685k | -50% | 2.0k | 349.49 | |
| Alnylam Pharmaceuticals (ALNY) | 0.1 | $665k | -46% | 4.1k | 163.39 | |
| Icon SHS (ICLR) | 0.1 | $535k | 2.2k | 243.18 | ||
| Zai Lab Adr (ZLAB) | 0.1 | $528k | +33% | 12k | 44.00 | |
| Agilent Technologies Inc C ommon (A) | 0.1 | $503k | -7% | 3.8k | 132.37 | |
| Incyte Corporation (INCY) | 0.1 | $465k | 5.9k | 79.35 | ||
| Biontech Se Sponsored Ads (BNTX) | 0.1 | $447k | -11% | 2.6k | 170.61 | |
| Sonendo (SONX) | 0.1 | $437k | -68% | 109k | 4.01 | |
| Legend Biotech Corp Spon Ads (LEGN) | 0.1 | $436k | +71% | 12k | 36.33 | |
| Stevanato Group Spa Ord Shs (STVN) | 0.1 | $395k | 20k | 20.11 | ||
| Guardant Health (GH) | 0.1 | $316k | 4.8k | 66.25 | ||
| Fusion Pharmaceuticals (FUSN) | 0.1 | $297k | 38k | 7.78 | ||
| Affimed Therapeutics B V (AFMD) | 0.1 | $295k | 68k | 4.37 | ||
| Dr Reddys Labs Adr (RDY) | 0.0 | $279k | +66% | 5.0k | 55.76 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.0 | $205k | 3.3k | 62.69 | ||
Past Filings by Sectoral Asset Management
SEC 13F filings are viewable for Sectoral Asset Management going back to 2010
- Sectoral Asset Management 2022 Q1 filed May 10, 2022
- Sectoral Asset Management 2021 Q4 filed Feb. 11, 2022
- Sectoral Asset Management 2021 Q3 filed Nov. 15, 2021
- Sectoral Asset Management 2021 Q2 filed Aug. 16, 2021
- Sectoral Asset Management 2021 Q1 filed May 14, 2021
- Sectoral Asset Management 2020 Q4 filed Feb. 12, 2021
- Sectoral Asset Management 2020 Q3 filed Nov. 13, 2020
- Sectoral Asset Management 2020 Q2 filed Aug. 13, 2020
- Sectoral Asset Management 2020 Q1 filed May 13, 2020
- Sectoral Asset Management 2019 Q4 filed Feb. 12, 2020
- Sectoral Asset Management 2019 Q3 filed Nov. 14, 2019
- Sectoral Asset Management 2019 Q2 filed Aug. 14, 2019
- Sectoral Asset Management 2019 Q1 filed May 14, 2019
- Sectoral Asset Management 2018 Q4 filed Feb. 12, 2019
- Sectoral Asset Management 2018 Q3 filed Nov. 14, 2018
- Sectoral Asset Management 2018 Q2 filed Aug. 13, 2018